Reviva Pharmaceuticals Holdings, Inc. RVPH
RVPH
Reviva Pharmaceuticals Holdings, Inc. RVPHW
Reviva Pharmaceuticals Holdings, Inc. EYEN
Eyenovia, Inc. CGTX
Cognition Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. KOD
Kodiak Sciences Inc. NLSP
NLS Pharmaceutics AG IRD
Opus Genetics, Inc. MTVA
MetaVia Inc. ARDS
Aridis Pharmaceuticals, Inc.
Reviva Pharmaceuticals Holdings, Inc. RVPHW
Reviva Pharmaceuticals Holdings, Inc. EYEN
Eyenovia, Inc. CGTX
Cognition Therapeutics, Inc. RNAZ
TransCode Therapeutics, Inc. KOD
Kodiak Sciences Inc. NLSP
NLS Pharmaceutics AG IRD
Opus Genetics, Inc. MTVA
MetaVia Inc. ARDS
Aridis Pharmaceuticals, Inc.
Performance
| Periode | RVPH | RVPHW | EYEN | CGTX | RNAZ | KOD | NLSP | IRD | MTVA | ARDS |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -3.68 % | -24.53 % | 749.47 % | 418.56 % | 25.11 % | 444.50 % | 30.37 % | 176.64 % | -32.57 % | 2 200.00 % |
| YTD | -67.67 % | -80.74 % | -15.94 % | 153.08 % | -79.54 % | 37.70 % | -19.27 % | 55.56 % | -53.66 % | 2 200.00 % |
| 1Y | -47.16 % | -45.83 % | -77.91 % | 329.17 % | -96.86 % | 310.73 % | -61.66 % | 56.80 % | -61.35 % | 2 200.00 % |
| 3Y | -83.29 % | -91.33 % | -95.80 % | 0.55 % | -100.00 % | 66.95 % | -90.74 % | 51.94 % | -61.35 % | -99.77 % |
| 5Y | -93.97 % | -89.38 % | -97.19 % | -85.67 % | -100.00 % | -22.42 % | -98.48 % | 51.94 % | -61.35 % | -99.97 % |
| 10Y | -93.31 % | -85.56 % | -98.98 % | -85.67 % | -100.00 % | 484.73 % | -98.48 % | 51.94 % | -61.35 % | -99.98 % |
| From the beginning | -93.31 % | -85.56 % | -98.98 % | -85.67 % | -100.00 % | 484.73 % | -98.48 % | 51.94 % | -61.35 % | -99.98 % |